Literature DB >> 11961135

Regulation of fibronectin fibrillogenesis by protein kinases in cultured rat osteoblasts.

Rong-Sen Yang1, Chih-Hsin Tang, Qing-Dong Ling, Shing-Hwa Liu, Wen-Mei Fu.   

Abstract

Fibronectin (Fn) plays an important role in the regulation of adhesion, migration, and maturation of osteoblasts. Fn fibrillogenesis is involved in the process of bone mineralization. To elucidate the regulatory role of protein kinases in the formation of fibrillar Fn matrix, Fn synthesis and assembly were examined in cultured osteoblasts. Osteoblasts assembled the endogenously released soluble Fn into immobilized form on the substratum in a time-dependent manner. Both 12-O-tetradecanoylphorbol-13 acetate (TPA) and forskolin increased the synthesis of Fn. However, the extracellular assembly of Fn fibril from both endogenously released and exogenously applied soluble Fn was increased by TPA but decreased by forskolin. Protein kinase C (PKC) inhibitors, such as H7, Ro 318220, and Gö 6976, inhibited Fn fibrillogenesis. These results suggest that the dynamic of Fn fibrillogenesis is differentially regulated by the activation of PKC and protein kinase A (PKA). Both classic and novel isoforms of PKC are involved in the action of TPA in osteoblasts. It has been reported that alpha5beta1 integrin is related to Fn fibrillogenesis. Immunocytochemistry and flow cytometry showed that TPA and forskolin increased and inhibited, respectively, the clustering and surface expression of alpha5 integrins. TPA and forskolin did not affect protein levels of alpha5 integrins. The Western blot and reverse transcriptase-polymerase chain reaction showed that protein and mRNA levels of beta1 integrins also were not affected by TPA and forskolin. These results suggest that TPA and forskolin may affect the surface expression of alpha5beta1 integrins. cAMP response element-binding protein phosphorylation is involved in the action of forskolin but not that of TPA. Our results suggest that PKC activation enhanced Fn fibrillogenesis, whereas PKA activation inhibited extracellular Fn fibrillogenesis in primary cultured osteoblasts. Cytosolic Fn synthesis and extracellular Fn assembly may be differentially regulated by the activation of PKA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961135     DOI: 10.1124/mol.61.5.1163

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

Review 1.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

2.  Matrix-specific suppression of integrin activation in shear stress signaling.

Authors:  A Wayne Orr; Mark H Ginsberg; Sanford J Shattil; Hans Deckmyn; Martin A Schwartz
Journal:  Mol Biol Cell       Date:  2006-08-23       Impact factor: 4.138

3.  Surface characterization and biocompatibility of titanium alloys implanted with nitrogen by Hardion+ technology.

Authors:  D M Gordin; T Gloriant; V Chane-Pane; D Busardo; V Mitran; D Höche; C Vasilescu; S I Drob; A Cimpean
Journal:  J Mater Sci Mater Med       Date:  2012-08-24       Impact factor: 3.896

4.  Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30.

Authors:  Jeffrey A Quinn; C Thomas Graeber; A Raymond Frackelton; Minsoo Kim; Jean E Schwarzbauer; Edward J Filardo
Journal:  Mol Endocrinol       Date:  2009-04-02

5.  Osteoporosis Prevention by Adlay ( Yì Yǐ: The Seeds of Coix Lachryma-Jobi L. var. ma-yuen Stapf) in a Mouse Model.

Authors:  Rong-Sen Yang; Yi-Hsiang Lu; Wenchang Chiang; Shing-Hwa Liu
Journal:  J Tradit Complement Med       Date:  2013-04

6.  Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear function.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2015-11-26       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.